Cargando…

Predicting patient ‘cost blooms’ in Denmark: a longitudinal population-based study

OBJECTIVES: To compare the ability of standard versus enhanced models to predict future high-cost patients, especially those who move from a lower to the upper decile of per capita healthcare expenditures within 1 year—that is, ‘cost bloomers’. DESIGN: We developed alternative models to predict bein...

Descripción completa

Detalles Bibliográficos
Autores principales: Tamang, Suzanne, Milstein, Arnold, Sørensen, Henrik Toft, Pedersen, Lars, Mackey, Lester, Betterton, Jean-Raymond, Janson, Lucas, Shah, Nigam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5253526/
https://www.ncbi.nlm.nih.gov/pubmed/28077408
http://dx.doi.org/10.1136/bmjopen-2016-011580
_version_ 1782498174305304576
author Tamang, Suzanne
Milstein, Arnold
Sørensen, Henrik Toft
Pedersen, Lars
Mackey, Lester
Betterton, Jean-Raymond
Janson, Lucas
Shah, Nigam
author_facet Tamang, Suzanne
Milstein, Arnold
Sørensen, Henrik Toft
Pedersen, Lars
Mackey, Lester
Betterton, Jean-Raymond
Janson, Lucas
Shah, Nigam
author_sort Tamang, Suzanne
collection PubMed
description OBJECTIVES: To compare the ability of standard versus enhanced models to predict future high-cost patients, especially those who move from a lower to the upper decile of per capita healthcare expenditures within 1 year—that is, ‘cost bloomers’. DESIGN: We developed alternative models to predict being in the upper decile of healthcare expenditures in year 2 of a sample, based on data from year 1. Our 6 alternative models ranged from a standard cost-prediction model with 4 variables (ie, traditional model features), to our largest enhanced model with 1053 non-traditional model features. To quantify any increases in predictive power that enhanced models achieved over standard tools, we compared the prospective predictive performance of each model. PARTICIPANTS AND SETTING: We used the population of Western Denmark between 2004 and 2011 (2 146 801 individuals) to predict future high-cost patients and characterise high-cost patient subgroups. Using the most recent 2-year period (2010–2011) for model evaluation, our whole-population model used a cohort of 1 557 950 individuals with a full year of active residency in year 1 (2010). Our cost-bloom model excluded the 155 795 individuals who were already high cost at the population level in year 1, resulting in 1 402 155 individuals for prediction of cost bloomers in year 2 (2011). PRIMARY OUTCOME MEASURES: Using unseen data from a future year, we evaluated each model's prospective predictive performance by calculating the ratio of predicted high-cost patient expenditures to the actual high-cost patient expenditures in Year 2—that is, cost capture. RESULTS: Our best enhanced model achieved a 21% and 30% improvement in cost capture over a standard diagnosis-based model for predicting population-level high-cost patients and cost bloomers, respectively. CONCLUSIONS: In combination with modern statistical learning methods for analysing large data sets, models enhanced with a large and diverse set of features led to better performance—especially for predicting future cost bloomers.
format Online
Article
Text
id pubmed-5253526
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-52535262017-01-25 Predicting patient ‘cost blooms’ in Denmark: a longitudinal population-based study Tamang, Suzanne Milstein, Arnold Sørensen, Henrik Toft Pedersen, Lars Mackey, Lester Betterton, Jean-Raymond Janson, Lucas Shah, Nigam BMJ Open Health Informatics OBJECTIVES: To compare the ability of standard versus enhanced models to predict future high-cost patients, especially those who move from a lower to the upper decile of per capita healthcare expenditures within 1 year—that is, ‘cost bloomers’. DESIGN: We developed alternative models to predict being in the upper decile of healthcare expenditures in year 2 of a sample, based on data from year 1. Our 6 alternative models ranged from a standard cost-prediction model with 4 variables (ie, traditional model features), to our largest enhanced model with 1053 non-traditional model features. To quantify any increases in predictive power that enhanced models achieved over standard tools, we compared the prospective predictive performance of each model. PARTICIPANTS AND SETTING: We used the population of Western Denmark between 2004 and 2011 (2 146 801 individuals) to predict future high-cost patients and characterise high-cost patient subgroups. Using the most recent 2-year period (2010–2011) for model evaluation, our whole-population model used a cohort of 1 557 950 individuals with a full year of active residency in year 1 (2010). Our cost-bloom model excluded the 155 795 individuals who were already high cost at the population level in year 1, resulting in 1 402 155 individuals for prediction of cost bloomers in year 2 (2011). PRIMARY OUTCOME MEASURES: Using unseen data from a future year, we evaluated each model's prospective predictive performance by calculating the ratio of predicted high-cost patient expenditures to the actual high-cost patient expenditures in Year 2—that is, cost capture. RESULTS: Our best enhanced model achieved a 21% and 30% improvement in cost capture over a standard diagnosis-based model for predicting population-level high-cost patients and cost bloomers, respectively. CONCLUSIONS: In combination with modern statistical learning methods for analysing large data sets, models enhanced with a large and diverse set of features led to better performance—especially for predicting future cost bloomers. BMJ Publishing Group 2017-01-11 /pmc/articles/PMC5253526/ /pubmed/28077408 http://dx.doi.org/10.1136/bmjopen-2016-011580 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Health Informatics
Tamang, Suzanne
Milstein, Arnold
Sørensen, Henrik Toft
Pedersen, Lars
Mackey, Lester
Betterton, Jean-Raymond
Janson, Lucas
Shah, Nigam
Predicting patient ‘cost blooms’ in Denmark: a longitudinal population-based study
title Predicting patient ‘cost blooms’ in Denmark: a longitudinal population-based study
title_full Predicting patient ‘cost blooms’ in Denmark: a longitudinal population-based study
title_fullStr Predicting patient ‘cost blooms’ in Denmark: a longitudinal population-based study
title_full_unstemmed Predicting patient ‘cost blooms’ in Denmark: a longitudinal population-based study
title_short Predicting patient ‘cost blooms’ in Denmark: a longitudinal population-based study
title_sort predicting patient ‘cost blooms’ in denmark: a longitudinal population-based study
topic Health Informatics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5253526/
https://www.ncbi.nlm.nih.gov/pubmed/28077408
http://dx.doi.org/10.1136/bmjopen-2016-011580
work_keys_str_mv AT tamangsuzanne predictingpatientcostbloomsindenmarkalongitudinalpopulationbasedstudy
AT milsteinarnold predictingpatientcostbloomsindenmarkalongitudinalpopulationbasedstudy
AT sørensenhenriktoft predictingpatientcostbloomsindenmarkalongitudinalpopulationbasedstudy
AT pedersenlars predictingpatientcostbloomsindenmarkalongitudinalpopulationbasedstudy
AT mackeylester predictingpatientcostbloomsindenmarkalongitudinalpopulationbasedstudy
AT bettertonjeanraymond predictingpatientcostbloomsindenmarkalongitudinalpopulationbasedstudy
AT jansonlucas predictingpatientcostbloomsindenmarkalongitudinalpopulationbasedstudy
AT shahnigam predictingpatientcostbloomsindenmarkalongitudinalpopulationbasedstudy